|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2200064564 |
|
最近更新日期: Date of Last Refreshed on: |
2022-10-11 23:34:06 |
|
注册时间: Date of Registration: |
2022-10-11 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
压力控制容量保证通气改善妇科肿瘤腹腔镜手术患者支气管粘液运输速度:一项双盲随机对照研究 |
|
Public title: |
Pressure-controlled ventilation volume-guaranteed mode improves bronchial mucus transport velocity in patients duringlaparoscopic surgery for gynecological oncology: a randomized controlled study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
压力控制容量保证通气改善妇科肿瘤腹腔镜手术患者支气管粘液运输速度:一项双盲随机对照研究 |
|
Scientific title: |
Pressure-controlled ventilation volume-guaranteed mode improves bronchial mucus transport velocity in patients duringlaparoscopic surgery for gynecological oncology: a randomized controlled study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
邓超 |
研究负责人: |
邓超 |
|
Applicant: |
Chao Deng |
Study leader: |
Chao Deng |
|
申请注册联系人电话: Applicant telephone: |
13565558780 |
研究负责人电话:
Study leader's |
13565558780 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1452793572@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
1452793572@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国新疆石河子大学医学院第一附属医院麻醉科 |
研究负责人通讯地址: |
中国新疆石河子大学医学院第一附属医院麻醉科 |
|
Applicant address: |
Department of Anesthesiology,First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang, China |
Study leader's address: |
Department of Anesthesiology,First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中国新疆石河子大学医学院第一附属医院麻醉科 |
||
|
Applicant's institution: |
Department of Anesthesiology,First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang, China |
||
|
研究负责人所在单位: |
中国新疆石河子大学医学院第一附属医院麻醉科 |
||
|
Affiliation of the Leader: |
Department of Anesthesiology,First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang, China |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KJ2022-144-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
石河子大学医学院第一附属医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the First Affiliated Hospital of Shihezi University School of Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-09-13 00:00:00 | ||
|
伦理委员会联系人: |
闫肃 |
||
|
Contact Name of the ethic committee: |
Su Yan |
||
|
伦理委员会联系地址: |
新疆石河子大学医学院第一附属医院科研科 |
||
|
Contact Address of the ethic committee: |
Department of Scientific Research, The First Affiliated Hospital of Shihezi University School of Medicine, Xinjiang |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
中国新疆石河子大学医学院第一附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang, China |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国新疆石河子大学医学院第一附属医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Department of Anesthesiology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
石河子大学课题ZZZC202063A |
||||||||||||||||||||||
|
Source(s) of funding: |
Project of Shihezi UniversityZZZC202063A |
||||||||||||||||||||||
|
研究疾病: |
纤毛运动功能 |
||||||||||||||||||||||
|
Target disease: |
Ciliary motor function |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
探究压力控制通气量保证模式对妇科肿瘤腹腔镜手术患者支气管粘液输送速度的影响 |
||||||||||||||||||||||
|
Objectives of Study: |
To explore the effect of pressure control ventilation mode on bronchial mucus delivery speed in patients undergoing laparoscopic surgery for gynecological tumors |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
所有计划在石河子大学医学院第一附属医院接受择期腹腔镜妇科肿瘤切除术的患者,年龄40-75岁,美国麻醉医师协会(ASA)身体状况I-II。 |
||||||||||||||||||||||
|
Inclusion criteria |
All patients scheduled for elective laparoscopic gynecologic tumor resection at the First Affiliated Hospital of Shihezi University School of Medicine were evaluated as eligible. Inclusion criteria included age 40 to 75 years and American Society of Anesthesiologists physical status I-II. |
||||||||||||||||||||||
|
排除标准: |
有呼吸道系统疾病及手术史、吸烟史或近期使用过已知影响BTV(肾上腺素受体拮抗剂、激素、抗胆碱能药物、茶碱和儿茶酚胺预计有气道困难、特异反应、)的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
included patients with a history of respiratory disease and surgery, smoking history, or recent use known to affect BTV(adrenoceptor antagonists, hormones, anticholinergic drugs, theophylline, and catecholamines expected to have airway difficulties, atopy, and so on). |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-10-10 00:00:00至 To 2022-12-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-10-10 00:00:00 至 To 2022-12-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
这是一项单中心、前瞻性、随机对照临床试验。使用SPSS 26.0软件程序(IBM SPSS统计,芝加哥,伊利诺伊州,美国)。计算机随机数法,40名受试者按1:1的比例分组,随机生成20个1或2的数字。规定编号1对应PCV-VG组,编号2对应VCV组。固定值为:122037 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
This was a single-center, prospective,, randomized controlled clinical trial. Using SPSS 26.0 softwareprogram (IBM SPSS Statistics, Chicago, Illinois,, USA). and computer random number method, 40 subjects were divided into groups with a ratio of 1:1, and 20 numbers of 1 or 2 were randomly generated. It was stip |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
向作者申请或向通讯作者申请,也向网络公开http://www.chictr.org.cn/index.aspx |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Apply to the author or to the corresponding author.It is also open to the Internet. http://www.chictr.org.cn/index.aspx |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
由研究和试验设计者自制表格,护士负责采集,另一个不参与研究的统计人员负责数据管理 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The study and trial designers created the forms, the nurse collected them, and another statistician who was not involved in the study managed the data |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |